In vivo molecular targeting effects of anti-Sp17- ICG-Der-02 on hepatocellular carcinoma evaluated by an optical imaging system

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Li, Fang Qiu ^a   Zhang, Shi Xin ^a   An, Lian Xiao ^b   Gu, Yue Qing ^b  

^a NANJING UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI SPERM PROTEIN 17 MONOCLONAL ANTIBODY; FLUORESCENT DYE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; CARRIER PROTEIN; DIAGNOSTIC AGENT; MEMBRANE ANTIGEN; SPA17 PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFRARED RADIATION; LIVER CELL CARCINOMA; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT; ANIMAL; DRUG ANTAGONISM; DRUG SCREENING; LIVER TUMOR; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952101702     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-25     Document Type: Article

References (22)

1. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. XH Peng X Qian H Mao AY Wang ZG Chen S Nie DM Shin, Int J Nanomed 1998 3 311 321
2. Cancer statistics, 2009. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun, CA Cancer J Clin 2009 59 225 49 10.3322/caac.20006 19474385
3. Nanotechnology applications in cancer. S Nie Y Xing GJ Kim JW Simons, Annu Rev Biomed Eng 2007 9 257 88 10.1146/annurev.bioeng.9.060906.152025 17439359 (Pubitemid 350246658)
4. Exploiting nanotechnology to target cancer. S Sengupta R Sasisekharan, Br J Cancer 2007 96 1315 19 17406364 (Pubitemid 46685778)
5. Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma. A Toma E Otsuji Y Kuriu K Okamoto D Ichikawa A Hagiwara H Ito T Nishimura H Yamagishi, Br J Cancer 2005 93 131 6 10.1038/sj.bjc.6602668 15970924 (Pubitemid 41076261)
6. Imaging in targeted delivery of therapy to cancer. G Dancey RH Begent T Meyer, Target Oncol 2009 4 201 17 10.1007/s11523-009-0119-8 19838639
7. Expression of the rabbit sperm protein Sp17 in COS cells and interaction of recombinant Sp17 with the rabbit zona pellucida. N Yamasaki RT Richardson MG O'Rand, Mol Reprod Dev 1995 40 48 55 10.1002/mrd.1080400107 7702869
8. Genes differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma. G Dong E Loukinova CW Smith Z Chen C Van Waes, J Cell Biochem Suppl 1997 28-29 90 100 10.1002/(SICI)1097-4644(1997)28/29+<90::AID-JCB10>3.0.CO;2-K 9589353 (Pubitemid 28246632)
9. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. SH Lim Z Wang M Chiriva-Internati Y Xue, Blood 2001 97 1508 1510 10.1182/blood.V97.5.1508 11222401 (Pubitemid 32183780)
10. Expression of sperm protein 17 (Sp17) in ovarian cancer. JM Straughn Jr DR Shaw A Guerrero SM Bhoola A Racelis Z Wang M Chiriva-Internati WE Grizzle RD Alvarez SH Lim TV Strong, Int J Cancer 2004 108 805 811 10.1002/ijc.11617 14712480 (Pubitemid 38112606)
11. Aberrant expression of sperm protein 17 increase migration and chemoresistance of human epithelial ovarian cancer cells. FQ Li YL Han Q Liu B Wu WB Huang SY Zeng, BMC cancer 2009 9 323 10.1186/1471-2407-9-323 19744347
12. Sperm protein 17 is expressed in human nervous system tumours. F Grizzi P Gaetani B Franceschini A Di Ieva P Colombo G Ceva-Grimaldi A Bollati EE Frezza E Cobos R Rodriguez y Baena N Dioguardi M Chiriva-Internati, MBC Cancer 2006 6 23 29
13. Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer. G Gupta R Sharma TK Chattopadhyay SD Gupta R Ralhan, Int J Cancer 2007 120 1739 1747 10.1002/ijc.22463 17230514 (Pubitemid 46399360)
14. Sperm protein 17 is highly expressed in endometrial and cervical cancers. FQ Li Q Liu YL Han B Wu HL Yin, BMC Cancer 2010 10 429 10.1186/1471-2407-10-429 20712874
15. Whole-body optical imaging in animal models to assess cancer development and progression. Eric L Kaijzel Gabri van der Pluijm Clemens WGM Lowik, Clin Cancer Res 2007 13 3490 3497 10.1158/1078-0432.CCR-07-0402 17575211 (Pubitemid 46955108)
16. Dual-labeled trastuzumab- based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. L Sampath S Kwon S Ke W Wang R Schiff ME Mawad EM Sevick-Muraca, J Nucl Med 2007 48 1501 1510 10.2967/jnumed.107.042234 17785729 (Pubitemid 47397400)
17. Optimization of the near infrared fluorescence labeling for in vivo monitoring of a protein drug distribution in animal model. H Qian Y Gu M Wang S Achilefu, J Fluorescence 2009 19 277 284 10.1007/s10895-008-0413-3
18. The targeting behavior of folate-nanohydrogel evaluated by near infrared imaging system in tumor-bearing mouse model. J Zhang D Deng Z Qian F Liu X Chen L An Y Gu, Pharm Res 2010 27 46 55 10.1007/s11095-009-0005-1 19904582
19. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. G Cabibbo A Crax Eur Rev Med Pharmacol Sci 2010 14 352 355 20496547
20. Combined real time PCR and immunohistochemical evaluation of sperm protein 17 as a cancer-testis antigen. Y Zhang Z Wang WR Robinson SH Lim, Eur J Haematol 2004 73 280 284 10.1111/j.1600-0609.2004.00308.x 15347315 (Pubitemid 39278854)
21. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. M Ogawa N Kosaka PL Choyke H Kobayashi, Cancer Res 2009 69 1268 1272 10.1158/0008-5472.CAN-08-3116 19176373
22. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. MR Lisy A Goermar C Thomas J Pauli U Resch-Genger WA Kaiser I Hilger, Radiology 2008 247 779 787 10.1148/radiol. 2472070123 18413884